Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia

Je-Hwan Lee, MD PhD, Hawk Kim, MD PhD, Young-Don Joo, MD, Won Sik Lee, Sung Hwa Bae, MD, Dae Young Zang, Jihyun Kwon, MD, Min Kyoung Kim, Junglim Lee, MD, Gyeong Won Lee, Jung-Hee Lee, MD PhD, Yunsuk Choi, MD PhD, Dae-Young Kim, MD PhD, Sung-Nam Lim, MD, Sang-Min Lee, Hun-Mo Ryoo, MD, Hyo Jung Kim, Myung Soo Hyun, Kyoo-Hyung Lee, MD PhD

Blood (2015) 126 (23): 2535.

https://doi.org/10.1182/blood.V126.23.2535.2535

Published: 2015

Journal Articles

Long-Term Follow-up of Continuous Imatinib Plus Combination Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Blood (2014) 124 (21): 3654.

https://doi.org/10.1182/blood.V124.21.3654.3654

Published: 2014

Journal Articles

Efficacy and Safety of Deferasirox Estimated By Serum Ferritin and Labile Plasma Iron Levels in Patients with Aplastic Anemia, Myelodysplastic Syndrome, or Hematologic Malignancy with Transfusional Iron Overload

Il hwan Kim, MD, Young Don Joo, MD PhD, Joon Ho Moon, MD PhD, Sung Nam Lim, MD, Sang Kyun Sohn, MD PhD, Gyeong Won Lee, Ho Sup Lee, Ki Young Kwon, MD PhD, Sung Hyun Kim, Kyung Tae Park, Joo Seop Chung, MD PhD, Won Sik Lee, MD PhD, Sang Min Lee, MD PhD, Myung Soo Hyun, MD PhD, Hawk Kim, Hun-Mo Ryoo, MD, Sung Hwa Bae

Blood (2014) 124 (21): 2676.

https://doi.org/10.1182/blood.V124.21.2676.2676

Published: 2014

Journal Articles

A Prospective, Multicenter Phase II Study Of Continuous Infusion Of FLAG For Patients Older Than 60 Years With Resistant Acute Myeloid Leukemia: A Comparison With Intensive Younger patients’ Trial

Hawk Kim, M.D., Je-Hwan Lee, M.D., Young-Don Joo, M.D., Sung-Hwa Bae, M.D., Ph.D., Jung-Hee Lee, Dae-Young Kim, M.D., Jae-Cheol Jo, Jae Hoo Park, Won Sik Lee, M.D., Hun-Mo Ryoo, MD, PhD, Sang-Kyu Park, Kyoo-Hyung Lee

Blood (2013) 122 (21): 3968.

https://doi.org/10.1182/blood.V122.21.3968.3968

Published: 2013

Journal Articles

Comparable Allogeneic Hematopoietic Cell Transplantation Outcome Of Haplo-Identical Family Donor With Matched Unrelated/Mismatched Family Donor In Adult Aplastic Anemia

Hawk Kim, M.D., Je-Hwan Lee, M.D., Young-Don Joo, M.D., Sung-Hwa Bae, Jung-Hee Lee, Dae-Young Kim, M.D., Jae-Cheol Jo, M.D., Jae Hoo Park, Won Sik Lee, M.D., Hun-Mo Ryoo, MD, Sang-Kyu Park, Kyoo Hyung Lee, M.D.

Blood (2013) 122 (21): 1230.

https://doi.org/10.1182/blood.V122.21.1230.1230

Published: 2013

Journal Articles

Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma

Hawk Kim, Je-Hwan Lee, M.D., Young Don Joo, M.D., Sung Hwa Bae, MD, Jung-Hee Lee, M.D., Dae-Young Kim, M.D., Won-Sik Lee, MD, Hun-Mo Ryoo, MD, PhD, Jung Lim Lee, Jae Hoo Park, Kyoo Hyung Lee, M.D.

Blood (2011) 118 (21): 4952.

https://doi.org/10.1182/blood.V118.21.4952.4952

Published: 2011

Journal Articles

A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia

Je-Hwan Lee, Young-Don Joo, Hawk Kim, Sung Hwa Bae, Min Kyoung Kim, Dae Young Zang, Jung-Lim Lee, Gyeong Won Lee, Jung-Hee Lee, Jae-Hoo Park, Dae-Young Kim, Won-Sik Lee, Hun Mo Ryoo, Myung Soo Hyun, Hyo Jung Kim, Young Joo Min, Yae-Eun Jang, Kyoo-Hyung Lee, for the Cooperative Study Group A for Hematology

Blood (2011) 118 (14): 3832–3841.

https://doi.org/10.1182/blood-2011-06-361410

Published: 2011

Journal Articles

Trough Plasma Imatinib Levels and ABCG2 Polymorphisms Are Correlated with Optimal Cytogenetic Responses at 6 Months After Treatment with Standard Dose of Imatinib In Newly Diagnosed CML

Blood (2010) 116 (21): 2272.

https://doi.org/10.1182/blood.V116.21.2272.2272

Published: 2010

Journal Articles

VEGFA and VEGFR2 Genetic Polymorphisms and Survival In Patients with Diffuse Large B Cell Lymphoma

Min Kyoung Kim, Cheolwon Suh, MD, Hyun Sook Chi, Hee Soon Cho, Kyung Hee Lee, Gyeong-Won Lee, In-Suk Kim, MD, PhD, Hyeon Seok Eom, Sun-Young Kong, MD, PhD, Sung Hwa Bae, Hun-Mo Ryoo, MD, PhD, Yeung-Chul Mun, MD, PhD, Hwasoon Chung, Myung Soo Hyun

Blood (2010) 116 (21): 994.

https://doi.org/10.1182/blood.V116.21.994.994

Published: 2010

Journal Articles

High Dose Dexamethasone Vs. Conventional Dose Prednisolone for Adults with Immune Thrombocytopenia: a Prospective Multicenter Phase III Trial.

Sung Hwa Bae, Hun-Mo Ryoo, Won Sik Lee, Young Don Joo, Kyoo Hyung Lee, Je-Hwan Lee, Jung-Hee Lee, Hawk Kim, Jae Hoo Park, Min Kyoung Kim, Myung Soo Hyun, Hyo Jung Kim, Dae Young Zang

Blood (2010) 116 (21): 3687.

https://doi.org/10.1182/blood.V116.21.3687.3687

Published: 2010

Journal Articles

Prospective Randomized Comparison of Cyclophosphamide Versus Cyclophosphamide Plus Fludarabine In Addition to Anti-Thymocyte Globulin for the Conditioning Therapy In Allogeneic Hematopoietic Cell Transplantation for Bone Marrow Failure Syndrome

Hawk Kim, Jae-Hoo Park, Je-Hwan Lee, Young Don Joo, Won-Sik Lee, Sung-Hwa Bae, MD, Hun-Mo Ryoo, MD, PhD, Myung Soo Hyun, Min Kyung Kim, Dae Young Zang, Hyo Jung Kim, Kyoo Hyung Lee

Blood (2010) 116 (21): 34.

https://doi.org/10.1182/blood.V116.21.34.34

Published: 2010

Journal Articles

Intensified 1st Cycle Rituximab (R) Plus 8 th Cycles of R-CHOP (cyclophosphamide, adriamycin, vincristine, prednisolone) Chemotherapy In Patients with Advanced or Bulky CD20 + Diffuse Large B-Cell Lymphoma (DLBCL); Open-Labelled, Multicenter Phase II CISL Study-Interim Analysis.

Jin Seok Kim, Won Seog Kim, Seok Jin Kim, MD, PhD, Hyeon Seok Eom, Deok-Hwan Yang, Yang Soo Kim, Hyo Jung Kim, Min Kyoung Kim, Suk-Joong Oh, Sung-Soo Yoon, Hun-Mo Ryoo, MD, PhD, Jae-Yong Kwak, Jae Hoon Lee, MD, PhD, Chul Won Choi, Hye Jin Kang, Yeung-Chul Mun, yun Deok Kim, Cheolwon Suh, MD

Blood (2010) 116 (21): 1786.

https://doi.org/10.1182/blood.V116.21.1786.1786

Published: 2010

Journal Articles

Induction Therapy with “3+7” Chemotherapy Plus ATRA Followed by Consolidations with Three Courses of Idarubicin Alone and Maintenance Therapy with ATRA in Newly Diagnosed Acute Promyelocytic Leukemia (APL) Has An Excellent Leukemia-Free Survival but Minimal Toxicity in Low and Intermediate Risk Groups.

Blood (2009) 114 (22): 2072.

https://doi.org/10.1182/blood.V114.22.2072.2072

Published: 2009

Journal Articles

Improved Survival of Patients with Multiple Myeloma and the Impact of Transplantation and Novel Agents: An Analysis of the Korean Multiple Myeloma Working Party (KMMWP).

Blood (2009) 114 (22): 4881.

https://doi.org/10.1182/blood.V114.22.4881.4881

Published: 2009

Journal Articles

The Prognostic Impact of Fluorescent-in Situ Hybridization (FISH) and Conventional Karyotying in Korean Multiple Myeloma Patients: A Retrospective Multicenter Study.

Blood (2009) 114 (22): 4902.

https://doi.org/10.1182/blood.V114.22.4902.4902

Published: 2009

Journal Articles

Comparative Analysis of Outcomes of Allogeneic Peripheral Blood Stem Cell Transplantation From Related and Unrelated Donors.

Byung Woog Kang, M.D., Shi Nae Kim, M.D., Joon Ho Moon, M.D., Joo-Seop Jung, Goon-Jae Cho, Deog Yeon Jo, Yeo-Kyeoung Kim, Hyeoung Joon Kim, MD, Hun-Mo Ryoo, Hyeon Seok Eom, MD, PhD, Sang Min Lee, Young-Don Joo, Jong Ho Won, Moo-Rim Park, MD, Min Kyoung Kim, Myung Soo Hyun, MD, PhD, Sang Kyun Sohn, M.D.

Blood (2009) 114 (22): 3381.

https://doi.org/10.1182/blood.V114.22.3381.3381

Published: 2009

Journal Articles

The Predictive Role of Germinal Center or Non-Germinal Center Phenotypes in Diffuse Large B-Cell Lymphoma Patients Receiving CHOP or R-CHOP

Sun-ah Lee, MD, Hun-Mo Ryoo, MD, PhD, Sung Hwa Bae, MD, Hyun Young Jung, MD, Saet Byul Jang, MD, Yoon Seop Keum, MD

Blood (2008) 112 (11): 5290.

https://doi.org/10.1182/blood.V112.11.5290.5290

Published: 2008

Journal Articles

Final Report of “Korean Multicenter AML-2000 Trial”: Intention to Treat Analysis Based on Cytogenetics Risk

Blood (2008) 112 (11): 2975.

https://doi.org/10.1182/blood.V112.11.2975.2975

Published: 2008

Journal Articles

Bortezomib-Based Induction Therapy Induces Better Responses and Outcomes of Autologous Stem Cell Transplantation in Newly Diagnosed Patients with Multiple Myeloma: The Results of Korean Multiple Myeloma Working Party Retrospective Study, KMM84

Seok Jin Kim, MD, PhD, Kihyun Kim, M.D./Ph.D., Jae Hoon Lee, Min Kyoung Kim, Jae-Yong Kwak, Hun-Mo Ryoo, Cheolwon Suh, Sung-Soo Yoon, Moon-Hee Lee, Yeung-Chul Mun, Hyo-Jin Lee, Chang-Ki Min, Jin Seok Kim, M.D., Ph.D., Hwi-Joong Yoon

Blood (2008) 112 (11): 5184.

https://doi.org/10.1182/blood.V112.11.5184.5184

Published: 2008

Journal Articles

Low Incidence of Thromboembolism in Asian Multiple Myeloma Patients Treated with Thalidomide: Do We Really Need Prophylaxis for Thromboembolism in Asian Population?

Youngil Koh, Soo-Mee Bang, MD, PhD, Jae Hoon Lee, Hwi-Joong Yoon, Young-Rok Do, PhD, Hun-Mo Ryoo, Nari Lee, Seok Jin Kim, MD, PhD, Sung-Soo Yoon, MD, PhD, Jong-Ho Won, MD, PhD, Yeung-Chul Mun, MD, PhD, Moon-Hee Lee, Jong-Youl Jin, MD, PhD, Hyo-Jung Kim, HyeonSeok Eom, MD, PhD, Min Kyoung Kim, MD, Hyun Chun Shin, Korean Multiple Myeloma Working Party

Blood (2008) 112 (11): 5146.

https://doi.org/10.1182/blood.V112.11.5146.5146

Published: 2008

NARROW

A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia

Long-Term Follow-up of Continuous Imatinib Plus Combination Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Efficacy and Safety of Deferasirox Estimated By Serum Ferritin and Labile Plasma Iron Levels in Patients with Aplastic Anemia, Myelodysplastic Syndrome, or Hematologic Malignancy with Transfusional Iron Overload

A Prospective, Multicenter Phase II Study Of Continuous Infusion Of FLAG For Patients Older Than 60 Years With Resistant Acute Myeloid Leukemia: A Comparison With Intensive Younger patients’ Trial

Comparable Allogeneic Hematopoietic Cell Transplantation Outcome Of Haplo-Identical Family Donor With Matched Unrelated/Mismatched Family Donor In Adult Aplastic Anemia

Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma

A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia

Trough Plasma Imatinib Levels and ABCG2 Polymorphisms Are Correlated with Optimal Cytogenetic Responses at 6 Months After Treatment with Standard Dose of Imatinib In Newly Diagnosed CML

VEGFA and VEGFR2 Genetic Polymorphisms and Survival In Patients with Diffuse Large B Cell Lymphoma

High Dose Dexamethasone Vs. Conventional Dose Prednisolone for Adults with Immune Thrombocytopenia: a Prospective Multicenter Phase III Trial.

Prospective Randomized Comparison of Cyclophosphamide Versus Cyclophosphamide Plus Fludarabine In Addition to Anti-Thymocyte Globulin for the Conditioning Therapy In Allogeneic Hematopoietic Cell Transplantation for Bone Marrow Failure Syndrome

Intensified 1st Cycle Rituximab (R) Plus 8 th Cycles of R-CHOP (cyclophosphamide, adriamycin, vincristine, prednisolone) Chemotherapy In Patients with Advanced or Bulky CD20 + Diffuse Large B-Cell Lymphoma (DLBCL); Open-Labelled, Multicenter Phase II CISL Study-Interim Analysis.

Improved Survival of Patients with Multiple Myeloma and the Impact of Transplantation and Novel Agents: An Analysis of the Korean Multiple Myeloma Working Party (KMMWP).

The Prognostic Impact of Fluorescent-in Situ Hybridization (FISH) and Conventional Karyotying in Korean Multiple Myeloma Patients: A Retrospective Multicenter Study.

Comparative Analysis of Outcomes of Allogeneic Peripheral Blood Stem Cell Transplantation From Related and Unrelated Donors.

The Predictive Role of Germinal Center or Non-Germinal Center Phenotypes in Diffuse Large B-Cell Lymphoma Patients Receiving CHOP or R-CHOP

Final Report of “Korean Multicenter AML-2000 Trial”: Intention to Treat Analysis Based on Cytogenetics Risk

Bortezomib-Based Induction Therapy Induces Better Responses and Outcomes of Autologous Stem Cell Transplantation in Newly Diagnosed Patients with Multiple Myeloma: The Results of Korean Multiple Myeloma Working Party Retrospective Study, KMM84

Low Incidence of Thromboembolism in Asian Multiple Myeloma Patients Treated with Thalidomide: Do We Really Need Prophylaxis for Thromboembolism in Asian Population?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only